| Issue Date | Title | Author(s) |
| 2022-04-01 | Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment. | Araujo, AM; Abaurrea, A; Azcoaga, P; López-Velazco, JI; Manzano, S; Rodriguez, J; Rezola, R; Egia-Mendikute, L; Valdés-Mora, F; Flores, JM; Jenkins, L; Pulido, L; Osorio-Querejeta, I; Fernández-Nogueira, P; Ferrari, N; Viera, C; Martín-Martín, N; Tzankov, A; Eppenberger-Castori, S; Alvarez-Lopez, I; Urruticoechea, A; Bragado, P; Coleman, N; Palazón, A; Carracedo, A; Gallego-Ortega, D; Calvo, F; Isacke, CM; Caffarel, MM; Lawrie, CH |
| 2022-10-03 | Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment. | Araujo, AM; Abaurrea, A; Azcoaga, P; López-Velazco, JI; Manzano, S; Rodriguez, J; Rezola, R; Egia-Mendikute, L; Valdés-Mora, F; Flores, JM; Jenkins, L; Pulido, L; Osorio-Querejeta, I; Fernández-Nogueira, P; Ferrari, N; Viera, C; Martín-Martín, N; Tzankov, A; Eppenberger-Castori, S; Alvarez-Lopez, I; Urruticoechea, A; Bragado, P; Coleman, N; Palazón, A; Carracedo, A; Gallego-Ortega, D; Calvo, F; Isacke, CM; Caffarel, MM; Lawrie, CH |
| 2021-07-19 | The Pandora’s Box of novel technologies that may revolutionize lung cancer | Rad, HS; Rad, HS; Shiravand, Y; Radfar, P; Arpon, D; Warkiani, ME; O'Byrne, K; Kulasinghe, A |
| 2021-01-01 | Understanding the tumor microenvironment for effective immunotherapy. | Sadeghi Rad, H; Monkman, J; Warkiani, ME; Ladwa, R; O'Byrne, K; Rezaei, N; Kulasinghe, A |
| 2021-02 | Characterizing the effect of substrate stiffness on the extravasation potential of breast cancer cells using a 3D microfluidic model. | Azadi, S; Tafazzoli Shadpour, M; Warkiani, ME |
| 2021-11-23 | Immuno-transcriptomic profiling of extracranial pediatric solid malignancies. | Brohl, AS; Sindiri, S; Wei, JS; Milewski, D; Chou, H-C; Song, YK; Wen, X; Kumar, J; Reardon, HV; Mudunuri, US; Collins, JR; Nagaraj, S; Gangalapudi, V; Tyagi, M; Zhu, YJ; Masih, KE; Yohe, ME; Shern, JF; Qi, Y; Guha, U; Catchpoole, D; Orentas, RJ; Kuznetsov, IB; Llosa, NJ; Ligon, JA; Turpin, BK; Leino, DG; Iwata, S; Andrulis, IL; Wunder, JS; Toledo, SRC; Meltzer, PS; Lau, C; Teicher, BA; Magnan, H; Ladanyi, M; Khan, J |
| 2021-11 | Application of extracellular vesicles in the diagnosis and treatment of prostate cancer: Implications for clinical practice. | Oey, O; Ghaffari, M; Li, JJ; Hosseini-Beheshti, E |
| 2023-02 | Immunotherapeutic targets in non-small cell lung cancer. | Sadeghirad, H; Bahrami, T; Layeghi, SM; Yousefi, H; Rezaei, M; Hosseini-Fard, SR; Radfar, P; Warkiani, ME; O'Byrne, K; Kulasinghe, A |
| 2019-12-01 | Upregulation of PD-L1 expression in breast cancer cells through the formation of 3D multicellular cancer aggregates under different chemical and mechanical conditions | Azadi, S; Aboulkheyr Es, H; Razavi Bazaz, S; Thiery, JP; Asadnia, M; Ebrahimi Warkiani, M |
| 2016-01-05 | Intravital FRAP Imaging using an E-cadherin-GFP Mouse Reveals Disease- and Drug-Dependent Dynamic Regulation of Cell-Cell Junctions in Live Tissue. | Erami, Z; Herrmann, D; Warren, SC; Nobis, M; McGhee, EJ; Lucas, MC; Leung, W; Reischmann, N; Mrowinska, A; Schwarz, JP; Kadir, S; Conway, JRW; Vennin, C; Karim, SA; Campbell, AD; Gallego-Ortega, D; Magenau, A; Murphy, KJ; Ridgway, RA; Law, AM; Walters, SN; Grey, ST; Croucher, DR; Zhang, L; Herzog, H; Hardeman, EC; Gunning, PW; Ormandy, CJ; Evans, TRJ; Strathdee, D; Sansom, OJ; Morton, JP; Anderson, KI; Timpson, P |
